BCM
FBIO icon

Bridgeway Capital Management’s Fortress Biotech FBIO Stock Holding History

Bridgeway Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$543K Sell
177,368
-5,000
-3% -$12.9K 0.01% 829
2026
Q1 		$509K Hold
182,368
– – 0.01% 824
2025
Q4 		$667K Buy
+182,368
New +$520K 0.01% 771
2014
Q1 		– Sell
-22,167
Closed -$874K – 1431
2013
Q4 		$874K Buy
+22,167
New +$856K 0.03% 791

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Bridgeway Capital Management's FBIO Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Fortress Biotech (FBIO) stake by 2.7% in Q2 2026, selling an estimated $12.9K and leaving 177,368 shares worth $543K. The position accounts for 0.01% of the portfolio, ranked #829.

Bridgeway Capital Management first reported a position in FBIO in Q4 2013 and has held it in 4 quarters since. The position peaked at $874K in Q4 2013. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Bridgeway Capital Management held 177,368 shares of Fortress Biotech worth $543K as of Q2 2026.
  • Bridgeway Capital Management sold 5,000 Fortress Biotech shares in Q2 2026, an estimated $12.9K.
  • Fortress Biotech made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #829 holding.
  • Bridgeway Capital Management first reported a position in Fortress Biotech in Q4 2013 and has held it in 4 quarters since.
  • Bridgeway Capital Management's Fortress Biotech position peaked at $874K in Q4 2013.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.